Farallon Capital Management's book
15 companies · priced for members| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | ▮ | ▮ | ▮ | ▮ |
| Mirador Therapeutics | — | ▮ | ▮ | ▮ | ▮ |
| Pentera | — | ▮ | ▮ | ▮ | ▮ |
+ 12 more companies · all 15, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | |||||
Farallon Capital Management portfolio at a glance
15 portfolio companies are on record for Farallon Capital Management, including Freenome, Pentera and Mirador Therapeutics. The book leans Biotechnology (2), Drug Discovery (2) and Decision/Risk Analysis (1).
9 of the 15 carry a recorded valuation.
Free account
See more of the book
- ·The top 10 names in the book — of 15 recorded positions
- ·Watchlist + alerts for Farallon Capital Management's activity